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The mechanism behind this association is unclear but does notMild renal insufficiency is associated with increased cardiovas-
appear to involve common risk factors such as hypertension,cular mortality: The Hoorn Study.
diabetes or hyperhomocysteinemia. Estimation of renal func-Background. Cardiovascular mortality is extremely high in
tion by relatively simple methods therefore may be a valuableend-stage renal disease. Cardiovascular mortality risk also is
tool for cardiovascular risk assessment over and above thatincreased in selected (high-risk) individuals with mild to mod-
provided by conventional risk factors. Our results were ob-erate impairment of renal function. It is not clear whether a
tained in a general middle-aged to elderly population, and thussimilar association exists in the general population and, if so,
have broad applicability.through what mechanisms. We investigated the association of
renal function with all-cause and cardiovascular mortality in a
population-based cohort and explored potential mechanisms
underlying any such relationship. End-stage renal disease is strongly associated with risk
Methods. An age-, sex-, and glucose-tolerance–stratified sam- of cardiovascular disease [1]. It is not clear whether aple (N 631) of a population-based cohort aged 50 to 75 years
similar association exists for patients with less severelywas followed prospectively. After up to 10.2 years of follow-
impaired renal function [2, 3], nor by which mechanismsup, 117 subjects had died (50 of cardiovascular causes). At
baseline, renal function was estimated by the serum creatinine any such association would be mediated. This question
level, the Cockcroft-Gault formula and Levey’s equation. is important because the incidence of renal functional
Results. At baseline, the mean age was 64  7 years, 48% impairment is increasing rapidly [4].
were men, 55% had hypertension, and 27% (by design) had
Estimation of glomerular filtration rate by gold-standardtype 2 diabetes. Serum creatinine was 91.7  19.0 mol/L;
clearance methods using exogenous tracers is unsuitablecreatinine clearance as estimated by the Cockroft-Gault for-
mula was 72.5  13.7 mL/min/1.73 m2, and the glomerular for large-scale studies. Population-based studies therefore
filtration rate (GFR) estimated by Levey’s equation was 67.8 require simpler estimates of renal function, such as the
12.1 mL/min/1.73 m2. Renal function was inversely associated serum creatinine level [5], the Cockcroft-Gault formula
with all-cause and with cardiovascular mortality. Relative risks [6] or Levey’s prediction equation, which may be most(95% confidence intervals) were 1.08 (1.04 to 1.13) and 1.11
accurate [7]. However, it is not known whether these(1.07 to 1.16) per 5 mol/L increase of serum creatinine; 1.07
estimates of renal function differ in their association with(0.98 to 1.17) and 1.15 (1.01 to 1.31) for each decrease of 5
mL/min/1.73 m2 creatinine clearance; and 1.15 (1.05 to 1.26) cardiovascular disease.
and 1.26 (1.12 to 1.42) for each decrease of 5 mL/min/1.73 m2 In view of these considerations, in a prospective, popu-
of GFR. These associations remained after adjusting for age, lation-based study, we investigated whether these estimatessex, glucose tolerance status, hypertension, prior cardiovascu-
of renal function were associated with cardiovascular mor-lar disease, low-density lipoprotein cholesterol, homocysteine,
tality. In addition, we explored potential mechanisms to(micro)albuminuria, von Willebrand factor, soluble vascular
adhesion molecule-1 and C-reactive protein. Analyses in dia- explain any such relationship, such as increased blood
betic and hypertensive subjects gave similar results. pressure, hyperhomocysteinemia, endothelial dysfunc-
Conclusion. Mild to moderate loss of renal function is strongly tion and inflammatory activity, all of which are associatedassociated with an increased risk of cardiovascular mortality.
with both impaired renal function and cardiovascular
disease [4, 8].
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fied for age, sex, and glucose tolerance. The Hoorn Study town, information on vital status was obtained from the
new local municipalities. For each subject, we deter-is a population-based cohort study of glucose tolerance
and other cardiovascular risk factors in a Caucasian pop- mined whether or not death had occurred during follow-
up, and if so, the date when death occurred. For allulation aged 50 to 75 years, in which the baseline mea-
surements were conducted from 1989 to 1992, as de- subjects who died, the cause of death was extracted from
the medical records of the general practitioner and thescribed previously [9, 10].
The present study population thus represents a strati- hospital of Hoorn, and classified according to the ninth
edition of the International Classification of Diseases [16].fied random sample of all subjects in the initial Hoorn
Study cohort. Cardiovascular mortality was defined as codes 390 – 459.
Information on cause of death could not be obtained for
Baseline investigations 16 (15%) of the deceased subjects and one subject was
lost to follow-up. The Hoorn Study was approved byRenal function was estimated by three calculations:
the serum creatinine level in mol/L [11]; the Cockcroft- the Ethical Review Committee of the VU University
Medical Centre. Written informed consent was obtainedGault formula in mL/min [(140  age) * body weight/
(creatinine * 72) * 0.85 if female] [6]; and Levey’s pre- from all participants.
diction equation in mL/min [170 * (creatinine)0.999 *
Statistical analyses(age)0.176 * (urea)0.170 * (albumin)0.318 * 0.762 if female]
[7]. The Cockroft-Gault and Levey’s formulas were both All analyses were performed using the SPSS 10.1 soft-
ware program for Windows 98 (SPSS, Chicago, IL, USA).expressed per 1.73 m2 body surface area [12]. (Formulas
are given in traditional units. To convert to International The Cox proportional hazard analyses were used to assess
the associations with all-cause and cardiovascular mor-System units multiply creatinine in mg/dL by 88.4, urea
in mg/dL by 0.357 and albumin in g/dL by 10.) tality of estimates of renal function and of cardiovascular
risk factors, such as hypertension, and risk indicators,
Other measurements such as von Willebrand factor, in all cases—because of
the stratification procedure—with an adjustment for age,Data were obtained on smoking habits, blood pres-
sure, weight, height, body mass index, waist-to-hip ratio, sex and glucose tolerance status. Risk factors and indica-
tors measured on a continuous scale were used as suchand ankle-brachial pressure index, as described else-
where [9, 10]. The following criteria were measured: in the regression models, except for body mass index and
waist-to-hip ratio, and levels of high-density lipoproteinserum levels of fasting glucose, two-hour post-load glu-
cose, glycated hemoglobin, fasting insulin, total choles- cholesterol, von Willebrand factor and C-reactive pro-
tein, because the association of these variables with mor-terol, high-density lipoprotein cholesterol, triglycerides,
homocysteine, von Willebrand factor, soluble vascular tality appeared to be non-linear. Therefore, obesity was
defined as a body mass index above 27 kg/m2 for mencell adhesion molecule-1 (sVCAM-1), and C-reactive
protein [9, 10, 13]. Resting electrocardiograms were and above 26 kg/m2 for women [17]; a high waist-to-hip
ratio as above 0.95 for men and above 0.80 for womenmade and classified according to the Minnesota coding
system [14]. Hypertension was defined as a blood pres- [18]; a low level of high-density lipoprotein cholesterol
as below 0.9 mmol/L [19]; and a high level of von Wille-sure 140 mm Hg systolic and/or 90 mm Hg diastolic,
according to JNC VI criteria [15] and/or the current brand factor or C-reactive protein as a level in the up-
per tertile (1.56 IU/mL and 2.84 mg/L, respectively)use of antihypertensive medication. Pulse pressure was
calculated by subtracting the mean diastolic blood pres- [20]. Levels of fasting insulin, triglyceride and sVCAM-1
were log-transformed because of a better fit of the regres-sure from the mean systolic blood pressure. (Micro)albu-
minuria was defined as an albumin-to-creatinine ratio sion model.
Multivariate Cox proportional hazard analyses were2.0 mg/mmol [10]. Subjects were classified as having
cardiovascular disease if they had a history of myocardial performed to assess whether the associations of estimates
of renal function with all-cause and cardiovascular mor-infarction, an electrocardiogram with a Minnesota code
1.1–1.3, 4.1–4.3, 5.1–5.3 or 7.1, had undergone coronary tality were independent of potential confounders. Re-
sults are described as relative risks (hazard ratios) withbypass surgery or angioplasty, had an ankle-brachial
pressure index less than 0.9 in either leg, and/or had 95% confidence intervals. Diabetes and hypertension are
often accompanied by impaired renal function. Interac-undergone a peripheral arterial bypass or amputation
for atherosclerotic disease. tion terms were used to investigate whether the associa-
tion between estimates of renal function and mortality
Follow-up differed according to blood pressure status or presence of
diabetes, because any such interaction might be clinicallyData on the subjects’ vital status on January 1, 2000
were collected from the mortality register of the munici- important. Two-sided P values less than 0.05 were con-
sidered statistically significant.pality of Hoorn. Of 51 subjects who had moved out of
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Table 1. Population characteristics and relative risk of all-cause and cardiovascular mortality associated with risk factors or risk indicators
All subjects (N  631) All-cause mortality Cardiovascular mortality
percentage, mean  SD, Difference in risk factor
Relative risk (95%CI)Risk factor or indicator median (iqr) or indicator
Male gender 48% yes vs. no 1.56 (1.08–2.26) 1.14 (0.81–2.48)
Age 647 years per 5 year increase 1.60 (1.38–1.86) 1.59 (1.26–1.86)
Diabetes mellitus type 2 27% yes vs. no 2.38 (1.65–3.43) 3.02 (1.73–5.28)
Glycated hemoglobin 5.91.3% per 1% increase of 1.14 (1.00–1.30) 1.10 (0.91–1.34)
hemoglobin
Fasting insulin 84 (63–119) pmol/L per 10% increasea 1.03 (1.01–1.07) 1.02 (0.96–1.09)
Body mass index 27.24.0 kg/m2 high vs. lowb 1.36 (0.91–2.04) 1.92 (1.00–3.69)
Waist-to-hip ratio 0.920.09 high vs. low 2.01 (1.17–3.49) 1.84 (0.80–4.23)
Total cholesterol 6.61.2 mmol/L per 1.0 mmol/L increase 1.11 (0.96–1.29) 1.14 (0.91–1.42)
High-density lipoprotein
cholesterol 1.30.4 mmol/L high vs. lowc 1.85 (1.16–2.96) 2.67 (1.37–5.18)
Low-density lipoprotein
cholesterol 4.51.1 mmol/L per 1.0 mmol/L increase 1.08 (0.92–1.28) 1.14 (0.89–1.46)
Triglycerides 1.6 (1.2–2.2) mmol/L per 10% increasea 1.05 (1.01–1.09) 1.05 (0.99–1.11)
Hypertension 55% yes vs. no 2.65 (1.74–4.04) 4.03 (1.96–8.30)
Systolic blood pressure 13919 mm Hg per 10 mm Hg increase 1.08 (0.98–1.19) 1.15 (0.99–1.33)
Diastolic blood pressure 8310 mm Hg per 10 mm Hg increase 1.03 (0.86–1.23) 1.05 (0.80–1.39)
Pulse pressure 5715 mm Hg per 10 mm Hg increase 1.14 (1.00–1.29) 1.24 (1.02–1.51)
Prior cardiovascular disease 24% yes vs. nof 2.13 (1.46–3.10) 2.82 (1.59–5.02)
Current smoking 28% yes vs. no 1.68 (1.13–2.49) 1.60 (0.86–2.99)
Homocysteine 12.65.8 mol/L per 5 mol/L increase 1.08 (0.96–1.21) 1.10 (0.95–1.28)
C-reactive protein 1.75 (0.83–3.80) mg/L high vs. lowd 1.42 (0.97–2.07) 1.80 (1.01–3.19)
von Willebrand factor 1.370.69 IU/mL high vs. lowd 1.76 (1.20–2.56) 2.08 (1.17–3.71)
sVCAM-1 1304.8 (1098.8–1594.6) per 10% increasea 1.04 (0.98–1.11) 1.14 (1.04–1.26)
g/L
Albumin 38.72.8 g/L per 1 g/L decrease 1.10 (1.10–1.18) 1.19 (1.08–1.32)
(Micro)albuminuria 11% yes vs. no 1.76 (1.12–2.78) 3.02 (1.63–5.60)
GFR
Serum creatinine level 91.719.0 mol/L per 5 mol/L increase 1.08 (1.05–1.12) 1.11 (1.07–1.16)
(80–100)
Cockcroft-Gault formula 72.513.7 mL/min per 5 mL/min decrease 1.04 (0.97–1.11) 1.15 (1.01–1.31)
(63.3–81.2)
Levey’s equation 67.812.1 mL/min per 5 mL/min decrease 1.15 (1.05–1.26) 1.26 (1.12–1.42)
(59.7–75.5)
Relative risks with 95% confidence intervals (95%CI) obtained with Cox proportional hazard analyses after adjustment for age, sex and glucose-tolerance-status,
except when this was the variable under consideration. Creatinine clearance, estimated by the Cockroft-Gault formula, and the glomerular filtration rate, estimated
by Levey’s equation, were both expressed per 1.73 m2 a log-transformed; b vs. 27 kg/m2 for males and  vs. 26 kg/m2 for females; c 	 vs. 0.9 mmol/L; d upper
tertile vs. lower tertile (1.56 IU/mL for von Willebrand factor and 2.84 mg/L for C-reactive protein levels); e albumin-to-creatinine ratio  vs. 2.0 mg/mmol;
f See Methods. Abbreviations are: sVCAM-1, soluble vascular cell adhesion molecule-1; SD, standard deviation; iqr, interquartile range.
RESULTS Estimates of renal function and all-cause and
cardiovascular mortalityFollow-up duration
All estimates of renal function were associated withMedian duration of the follow-up was 8.74 (range 0.46
both all-cause and cardiovascular mortality, so that an im-to 10.19) years. During follow-up, 117 of 631 subjects
paired renal function was accompanied by a higher mor-died, 50 (43%) of cardiovascular disease.
tality risk (Tables 2 and 3). The highest relative risk was
seen for Levey’s equation (model 1; Fig. 1). If expressedClinical characteristics
per 1 SD change in the renal function estimate, the rela-
Table 1 shows the baseline characteristics of the study tive risks of cardiovascular disease in model 1 were 1.49
population. The serum creatinine level was 91.7  19.0 (95% confidence interval, 1.28 to 1.73) for serum creati-
( SD) mol/L. Mean creatinine clearance, as estimated nine, 1.47 (1.04 to 2.08) for the Cockroft-Gault formula,
by the Cockcroft-Gault formula, was 72.5 13.7 ( SD) and 1.77 (1.33 to 2.34) for Levey’s equation. Adjustment
mL/min/1.73 m2, and mean glomerular filtration rate for potential confounders did not materially change the
(GFR), as estimated by Levey’s prediction equation, was relative risks (models 2 to 8). Adding body mass index or
67.8  12.1 ( SD) mL/min/1.73 m2. Table 1 also shows waist-to-hip ratio, or replacing hypertension by systolic,
the relative risks of mortality associated with risk factors diastolic or pulse pressure did not influence the associa-
and risk indicators. The relative risks for the estimates tions either (data not shown). These results did not differ
of renal function are expressed per a 5 unit increase for according to the blood pressure level, or the presence of
hypertension or diabetes (P values for interaction0.10).creatinine and a 5 unit decrease for the other estimates.
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Table 2. Relative risks of all-cause mortality associated with the different estimates of renal function
All-cause mortality (N  117) All subjects (N  608)a relative risk (95%CI)
Model Added variables Serum creatinine level Cockcroft-Gault formula Levey’s equation
1. Age, sex, glucose tolerance status 1.08 (1.04–1.13) 1.07 (0.98–1.17) 1.15 (1.05–1.26)
2. Model 1  prior CVD  hypertension 1.07 (1.03–1.11) 1.07 (0.98–1.17) 1.12 (1.04–1.21)
3. Model 2  LDL cholesterol 1.07 (1.03–1.11) 1.06 (0.97–1.16) 1.12 (1.04–1.21)
4. Model 2  homocysteine 1.07 (1.03–1.11) 1.07 (0.98–1.17) 1.12 (1.03–1.23)
5. Model 2  (micro)albuminuria 1.07 (1.03–1.11) 1.07 (0.98–1.17) 1.11 (1.02–1.21)
6. Model 2  von Willebrand factor 1.06 (1.02–1.10) 1.08 (0.99–1.18) 1.12 (1.04–1.21)
7. Model 2  sVCAM-1 1.07 (1.03–1.11) 1.08 (0.99–1.18) 1.13 (1.04–1.22)
8. Model 2  C-reactive protein 1.08 (1.03–1.11) 1.08 (0.99–1.18) 1.13 (1.04–1.22)
Variables are defined in the legend to Table 1. Abbreviations are: CVD, cardiovascular disease; sVCAM-1, soluble vascular cell adhesion molecule-1.
a Complete data were available in 608 individuals
Table 3. Relative risks of cardiovascular mortality associated with the different estimates of renal function
Cardiovascular mortality (N  50) All subjects (N  608) relative risk (95%CI)
Model Added variables Serum creatinine level Cockcroft-Gault formula Levey’s equation
1. Age, sex, glucose tolerance status 1.11 (1.07–1.16) 1.15 (1.01–1.31) 1.26 (1.12–1.42)
2. Model 1  prior CVD  hypertension 1.09 (1.05–1.13) 1.14 (1.01–1.28) 1.22 (1.09–1.35)
3. Model 2  LDL cholesterol 1.09 (1.05–1.13) 1.14 (1.01–1.28) 1.22 (1.09–1.35)
4. Model 2  homocysteine 1.09 (1.04–1.15) 1.14 (1.01–1.30) 1.22 (1.08–1.37)
5. Model 2  (micro)albuminuria 1.08 (1.04–1.13) 1.13 (1.00–1.27) 1.19 (1.05–1.33)
6. Model 2  von Willebrand factor 1.08 (1.04–1.13) 1.14 (1.01–1.28) 1.20 (1.07–1.33)
7. Model 2  sVCAM-1 1.09 (1.05–1.13) 1.14 (1.01–1.28) 1.19 (1.06–1.34)
8. Model 2  C-reactive protein 1.09 (1.05–1.14) 1.14 (1.02–1.29) 1.21 (1.08–1.36)
Variables are defined in the legend to Table 1. Abbreviations are: CVD, cardiovascular disease; sVCAM-1, soluble vascular cell adhesion molecule-1.
Additional analyses inine level, the Cockcroft-Gault formula or Levey’s pre-
diction equation. According to Levey’s equation, glo-As age and sex were part of the Cockcroft-Gault for-
merular filtration rate varied between 16.8 and 116.9 mL/mula and Levey’s equation, and were added to the analy-
min/1.73 m2. Within this range, a decrease in glomerularses with serum creatinine as key independent variable,
filtration rate of 5 mL/min/1.73 m2 was associated withall models were tested without these (stratification) vari-
a 26% increase in risk of cardiovascular death. Thus, aables. This did not materially influence our results. For
decrease from 90 to 60 mL/min/1.73 m2 was associatedexample, the cardiovascular mortality risks, without age
with fourfold (that is, 1.266) increase in risk of cardiovas-and sex, for creatinine, creatinine clearance and glomer-
cular death. Surprisingly, the association between mildular filtration rate were 1.10 (1.06–1.14), 1.16 (1.07–1.26)
renal insufficiency and cardiovascular mortality couldand 1.29 (1.16–1.44), respectively (other data not shown).
not be explained by the presence of hypertension, diabe-Further analyses to exclude the effects of modification
tes or prior cardiovascular disease, the lipid profile, theby the presence of hypertension or diabetes confirmed
homocysteine level, or by markers of endothelial dys-the consistency of the results, as the association between
function or inflammation. The mechanism responsiblerenal function and cardiovascular mortality was similar
for the association thus remains unclear.regardless of the presence or absence of hypertension
Our data are consistent with results of most, but not allor diabetes (data not shown).
[21], previous studies on the association between minorResults were similar when subjects with GFR 	30
renal impairment and cardiovascular disease that havemL/min/1.73 m2 according to Levey’s equation (N  4)
targeted selected populations, such as pre-dialysis pa-were excluded from the analyses.
tients [22], patients with a recent stroke [23] or a myocar-No violations of the Cox’s proportional hazard as-
dial infarction [24], patients at high risk of cardiovascularsumption were observed.
disease [25], patients with hypertension [26–28] and mid-
dle-aged men [29].
DISCUSSION Population-based studies, however, are scarce and
have shown discordant results [2, 3, 30]. In the Cardiovas-This population-based study shows that relatively
small impairments of renal function are associated with cular Health Study, serum creatinine levels greater than
133 mol/L were associated with a 71% increase in riskincreased risk of cardiovascular mortality, regardless of
whether renal function was estimated by the serum creat- of all-cause mortality [30]. However, the Framingham
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knowledge, has not been tested in individuals without
clinically evident renal disease.
Our study supports the hypothesis that renal function
itself is implicated in the association with cardiovascular
mortality. Firstly, despite their different constructs, all
three estimates of renal function were consistently asso-
ciated with mortality. Secondly, the associations between
estimates of renal function and mortality were stronger
for cardiovascular than for all-cause mortality. Taken to-
gether, these findings argue against the idea that our re-
sults simply reflect poor health at baseline, in which case
one might expect associations with all-cause and cardio-
vascular mortality of similar strength, or an association
of mortality with Levey’s equation (which incorporates
serum albumin, a known marker of poor health) but not
with the other renal function estimates.
One would anticipate that the association between
renal function and cardiovascular mortality would be
explained, at least in part, by other risk factors and indi-
cators, such as hypertension and endothelial dysfunction.Fig. 1. Cardiovascular survival (Kaplan-Meier) according to tertiles of
Individually, all these variables have been identified notglomerular filtration rate (GFR), estimated by Levey’s equation and
expressed per mL/min/1.73 m2. only as components of the atherothrombotic process [8],
but also as associated with impaired renal function [4].
Yet, in our study, the association between estimates of
renal function and mortality remained after adjustment
Study showed that serum creatinine levels between 136 for these risk factors and indicators (compare Tables 2
and 265 mol/L for men and between 120 and 265 and 3). The explanation for these findings is not clear.
mol/L for women were associated with all-cause mor- First, we cannot entirely exclude the phenomenon of
tality in men, but not in women. In addition, associations residual confounding. For example, insufficient accuracy
with cardiovascular mortality were not significant in ei- of blood pressure measurements may result in an under-
ther sex after adjustment for conventional cardiovascular estimation of the confounding role of blood pressure in
risk factors (that is, diabetes, hypertension and prevalent explaining the link between impaired renal function and
cardiovascular disease) [2]. Finally, results from the mortality. On the other hand, the fact that blood pressure
NHANES I study showed that moderate renal insuffi- was related to mortality (Table 1) illustrates that the ac-
ciency, defined as a creatinine of 104 to 146 mol/L for curacy of measurement was sufficient to allow this (ex-
women and 122 to 177 mol/L in men, was significantly pected) relationship to appear. An additional argument
associated with both all-cause and cardiovascular mortal- against residual confounding is the finding that the point
ity, but both associations lost significance after adjust- estimates of the associations between renal function and
ment for traditional cardiovascular risk factors [3]. These mortality were very similar before and after various ad-
different results may be related to the fact that the mor- justments (Tables 2 and 3). Second, we cannot exclude
tality rate in these studies [2, 3, 30] was lower than in that some of the variables in our study insufficiently re-
our study. In addition, the NHANES I study used a flect the processes they are intended to measure. For
narrower definition of renal insufficiency than our cur- example, we used plasma levels of von Willebrand factor
rent study. and soluble vascular cell adhesion molecule-1 as estimates
Levey’s equation may provide a more accurate method of endothelial dysfunction, but this is insufficient to fully
to estimate renal function than the Cockcroft-Gault for- describe the complexity of alterations in the function of
mula [7]. Our data support this concept in that Levey’s the vascular endothelium. Finally, the association between
equation showed the strongest association with mortality renal function and mortality may reflect an unmeasured
(because the most accurate estimate of renal function risk factor induced by impaired renal function, which
would be expected to show the strongest association), then causes cardiovascular disease, or be an outcome of
and in that Levey’s equation had a smaller SD than the an underlying pathological process that affects both GFR
Cockroft-Gault formula, which overestimates the true and risk of cardiovascular mortality (for example, athero-
GFR at high values of serum creatinine and underesti- sclerosis) [32]. These possibilities require further study.
mates GFR at low values of serum creatinine [31]. How- Two final limitations of our data should be kept in
mind. First, we studied a relatively healthy Caucasianever, it must be stressed that Levey’s equation, to our
Henry et al: Mild renal insufficiency and death 1407
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